These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4007736)

  • 1. [Visually evoked potentials in Wilson's disease].
    Hamann KU; Hellner KA; Müller-Jensen A; Zschocke S
    Fortschr Ophthalmol; 1985; 82(2):194-6. PubMed ID: 4007736
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnostic value of multi-modality evoked potentials in Wilson's disease.
    Arendt G; Hefter H; Stremmel W; Strohmeyer G
    Electromyogr Clin Neurophysiol; 1994; 34(3):137-48. PubMed ID: 8045245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of corticospinal tract in Wilson's disease. A study of three cases with transcranial stimulation.
    Berardelli A; Inghilleri M; Priori A; Thompson PD; Fabri S; Fieschi C; Manfredi M
    Mov Disord; 1990; 5(4):334-7. PubMed ID: 2259359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuromuscular transmission and acetylcholine receptor antibodies in penicillamine-treated Wilson's disease patients.
    Anlar B; Kuruoğlu R; Varli K; Topçu M
    Muscle Nerve; 1996 May; 19(5):676-7. PubMed ID: 8618573
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient with late-onset Wilson's disease: deterioration with penicillamine.
    Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
    Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
    [No Abstract]   [Full Text] [Related]  

  • 7. [Wilson's disease (hepatolenticular degeneration)].
    Bickel H
    Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evolution of nocturnal sleep in a case of Wilson's disease].
    Ferrari E; Puca FM; Specchio LM; Perniola T; Leomanni R
    Acta Neurol Quad (Napoli); 1979; 39():165-72. PubMed ID: 555233
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual pathway abnormalities Wilson's disease: an electrophysiological study using electroretinography and visual evoked potentials.
    Satishchandra P; Ravishankar Naik K
    J Neurol Sci; 2000 May; 176(1):13-20. PubMed ID: 10865087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in pancreatic secretion: VIII. Pancreatic function in patients with Wilson's disease.
    Dreiling DA; Grateron H
    Mt Sinai J Med; 1983; 50(4):335-7. PubMed ID: 6196633
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
    Hansen J; Andersen OS
    Ugeskr Laeger; 1969 Jul; 131(31):1306-9. PubMed ID: 5824791
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrophysiological changes of the brain in Wilson's disease under D-penicillamine treatment].
    Fujita T; Fujita H; Okawa M; Yokoi S
    Rinsho Shinkeigaku; 1976 May; 16(5):381-8. PubMed ID: 986276
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
    Farinati F; Cardin R; Mestriner C; Sturniolo GC; Naccarato R
    Am J Gastroenterol; 1995 Dec; 90(12):2264-5. PubMed ID: 8540540
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of neurologic manifestations of Wilson's disease using penicillamine].
    Hartl J; Hauftová D
    Cesk Neurol; 1970 Mar; 33(2):89-93. PubMed ID: 5417217
    [No Abstract]   [Full Text] [Related]  

  • 17. [Wilson's disease treated by penicillamine: favorable effect].
    Petit H
    Lille Med; 1968 Dec; 13(10):1132-4. PubMed ID: 5711646
    [No Abstract]   [Full Text] [Related]  

  • 18. [Penicillamine in the treatment of Wilson's disease. Clinical picture].
    Hauftová D; Hartl J; Seidlová V; Růzicková R; Kubĕna K; Slavícek J
    Vnitr Lek; 1970 Apr; 16(4):337-43. PubMed ID: 5429582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Wilson's disease. Presentation of a case with special reference to the study of evoked visual potentials].
    Marietti G; Pantanella P; Chiaretti A; Parenti D; Stabile A; Falsini B
    Minerva Pediatr; 1990 Nov; 42(11):489-93. PubMed ID: 2082176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotypies in Wilson's disease.
    Yorio AA; Mesri JC; Pagano MA; Lera G
    Mov Disord; 1997 Jul; 12(4):614-6. PubMed ID: 9251089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.